Abciximab inhibits the migration and invasion potential of human coronary artery smooth muscle cells

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 12, 2000, Pages 2195-2206

  Blindt, Rüdiger ^a   Bosserhoff, Anja Katrin ^a   Zeiffer, Ute ^a   Krott, Nicole ^a   Hanrath, Peter ^a   Vom Dahl, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Angioplasty; Cell culture; Extracellular matrix; Restenosis; Smooth muscle

Indexed keywords

ABCIXIMAB; COLLAGEN TYPE 1; COLLAGEN TYPE 4; INTEGRIN; INTEGRIN RECEPTOR; LAMININ; MONOCLONAL ANTIBODY LM 609; VITRONECTIN;

ARTERY MUSCLE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; COLORIMETRY; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; DOSE RESPONSE; FLOW CYTOMETRY; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESTENOSIS;

EID: 0034502280     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1245     Document Type: Article

References (51)

1. Non-operative dilatation of coronary-artery stenosis: Percutaneous transluminal coronary angioplasty
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina
4. A call for provisional stenting: The balloon is back!
5. Artery size, neointima, and remodeling: Time for some standards
6. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty
7. Growth factor expression of human arterial smooth muscle cells and endothelial cells in a transfilter coculture system
8. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor
9. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle ceils to migrate in response to insulin-like growth factor
10. Integrin signaling
11. Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: Evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation
12. The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells
13. Dynamic expression of alpha I beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes
14. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix
15. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro
16. The role of integrins in saphenous vein vascular smooth muscle cell migration
17. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro
18. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA
19. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation
20. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
21. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
22. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
23. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins
24. Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients
25. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial. EPISTENT Investigators
26. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: One-year outcome in the EPILOG trial. Evaluation in PTCA to improve long-term outcome with abciximab GP IIb/IIIa blockade
27. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor
28. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
29. The smooth muscle cell II. Growth of smooth muscle in culture and formation of elastic fibers
30. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
31. A rapid in vitro assay for quantitating the invasive potential of tumor cells
32. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components
33. Heparin interactions with cultured human vascular endothelial and smooth muscle cells: Incidence on vascular smooth muscle cell proliferation
34. Human smooth muscle cells of the aorta and vena cava: Different sensitivity to the inhibition of proliferation by heparin in vitro
35. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor
36. The inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alphavbeta3 integrin complex is reversed by activated calcium/calmodulin-dependent protein kinase II
37. Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration
38. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
39. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor beta1 and by platelet-derived growth factor-BB
40. Stimulation of migration of human aortic smooth muscle cells by vitronectin: Implications for atherosclerosis
41. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary ntervention. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication
42. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty
43. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade
44. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation
45. Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasntinogen activator in dogs
46. A rapid in vitro assay for quantitating the invasive potential of tumor cells
47. Use of a reconstituted basement membrane to study the invasiveness of tumor cells
48. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid
49. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent
50. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2)
51. Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis